Learn More
Description
Specifications
Specifications
| Antigen | SETDB2 |
| Applications | Chemotaxis, ChIP Assay, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Peptide ELISA, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Dilution | Western Blot 1 - 3 ug/mL, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Peptide ELISA Detection limit 1:1000, Chromatin Immunoprecipitation (ChIP) |
| Formulation | Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA with 0.02% Sodium Azide |
| Gene Accession No. | NP_114121. |
| Gene Alias | C13orf4, chromosome 13 open reading frame 4, chronic lymphocytic leukemia deletion region 8, Chronic lymphocytic leukemia deletion region gene 8 protein, CLLD8DKFZp761J1217, DKFZp586I0123, EC 2.1.1.43, histone-lysine N-methyltransferase SETDB2, KMT1FCLLL8, Lysine N-methyltransferase 1F, SET domain bifurcated 2, SET domain, bifurcated 2 |
| Gene Symbols | SETDB2 |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
